Gary Shienbaum

491 total citations
9 papers, 395 citations indexed

About

Gary Shienbaum is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Gary Shienbaum has authored 9 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 5 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Oncology. Recurrent topics in Gary Shienbaum's work include Retinal Diseases and Treatments (6 papers), Retinal Imaging and Analysis (5 papers) and Ocular Oncology and Treatments (3 papers). Gary Shienbaum is often cited by papers focused on Retinal Diseases and Treatments (6 papers), Retinal Imaging and Analysis (5 papers) and Ocular Oncology and Treatments (3 papers). Gary Shienbaum collaborates with scholars based in United States. Gary Shienbaum's co-authors include Carl D. Regillo, Christopher Fecarotta, Richard Kaiser, Omesh P. Gupta, Avni H. Patel, William Tasman, Harry W. Flynn, David S. Boyer, Benjamin J. Thomas and Philip J. Rosenfeld and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Gary Shienbaum

9 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Shienbaum United States 6 383 332 30 9 6 9 395
Nobuhiro Terao Japan 12 395 1.0× 280 0.8× 31 1.0× 7 0.8× 5 0.8× 26 412
Jung Il Han South Korea 11 396 1.0× 292 0.9× 20 0.7× 7 0.8× 2 0.3× 35 405
Seigo Yoneyama Japan 13 484 1.3× 336 1.0× 50 1.7× 14 1.6× 16 2.7× 35 505
Wataru Kikushima Japan 14 525 1.4× 373 1.1× 39 1.3× 10 1.1× 7 1.2× 42 551
Marie Thulliez United States 8 447 1.2× 358 1.1× 61 2.0× 10 1.1× 14 2.3× 9 485
Darren Bell United States 8 314 0.8× 229 0.7× 33 1.1× 20 2.2× 8 1.3× 10 338
Chrystel Feller Switzerland 3 401 1.0× 316 1.0× 16 0.5× 10 1.1× 6 1.0× 5 428
David G. Dodwell United States 8 327 0.9× 154 0.5× 24 0.8× 14 1.6× 4 0.7× 10 345
Christopher Fecarotta United States 6 341 0.9× 302 0.9× 24 0.8× 25 2.8× 6 1.0× 7 362
Fayyaz Musa United Kingdom 9 245 0.6× 242 0.7× 23 0.8× 29 3.2× 6 1.0× 13 308

Countries citing papers authored by Gary Shienbaum

Since Specialization
Citations

This map shows the geographic impact of Gary Shienbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Shienbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Shienbaum more than expected).

Fields of papers citing papers by Gary Shienbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Shienbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Shienbaum. The network helps show where Gary Shienbaum may publish in the future.

Co-authorship network of co-authors of Gary Shienbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Shienbaum. A scholar is included among the top collaborators of Gary Shienbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Shienbaum. Gary Shienbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Thomas, Benjamin J., Gary Shienbaum, David S. Boyer, & Harry W. Flynn. (2013). Evolving strategies in the management of diabetic macular edema: clinical trials and current management. Canadian Journal of Ophthalmology. 48(1). 22–30. 33 indexed citations
2.
Nahas, Zayna, Gary Shienbaum, William E. Smiddy, & Harry W. Flynn. (2013). Hypopyon and Pseudoendophthalmitis 1 Month After Vitrectomy for Retinal Detachment With Subretinal Hemorrhage. Ophthalmic surgery, lasers & imaging retina. 44(3). 281–283. 1 indexed citations
3.
Shienbaum, Gary, et al.. (2013). Management of Submacular Hemorrhage Secondary to Neovascular Age-Related Macular Degeneration With Anti–Vascular Endothelial Growth Factor Monotherapy. American Journal of Ophthalmology. 155(6). 1009–1013. 3 indexed citations
4.
Shienbaum, Gary, Omesh P. Gupta, Christopher Fecarotta, et al.. (2011). Bevacizumab for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen: Clinical and Economic Impact. American Journal of Ophthalmology. 153(3). 468–473.e1. 67 indexed citations
5.
Shienbaum, Gary, Omesh P. Gupta, Christopher Fecarotta, Carl D. Regillo, & Richard Kaiser. (2010). Management of Neovascular Age-Related Macular Degeneration Using Bevacizumab With the Treat and Extend Regimen: Clinical Results and Economic Impact. Investigative Ophthalmology & Visual Science. 51(13). 905–905. 33 indexed citations
6.
Gupta, Omesh P., Gary Shienbaum, Avni H. Patel, et al.. (2010). A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. 117(11). 2134–2140. 229 indexed citations
7.
Shah, Chirag P., Gary Shienbaum, Carol L. Shields, et al.. (2010). NEOVASCULAR GLAUCOMA AS THE PRESENTING SIGN OF METASTATIC SMALL CELL LUNG CARCINOMA. Retinal Cases & Brief Reports. 5(1). 26–29. 2 indexed citations
8.
Shienbaum, Gary & William Tasman. (2006). COATS DISEASE. Retina. 26(4). 422–424. 21 indexed citations
9.
Shienbaum, Gary & William Tasman. (2006). COATS DISEASE. Retina. 26(4). 422–424. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026